Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Flora M Haaijer-Ruskamp

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
British Journal of Clinical Pharmacology|April 22, 2017
Impact of adverse drug events and treatment satisfaction on patient adherence with antihypertensive medication - a study in ambulatory patientsDerbew Fikadu Berhe, Katja Taxis, Flora M Haaijer-Ruskamp, et al.
The Journal of Antimicrobial Chemotherapy|February 25, 2005
Improving compliance with hospital antibiotic guidelines: a time-series intervention analysisPeter G M Mol, Jaap E Wieringa, Prashant V Nannanpanday, et al.
Quality & Safety in Health Care|June 30, 2010
Comparison of methods for identifying patients at risk of medication-related harmJasperien E van Doormaal, Mirjam K Rommers, Jos G W Kosterink, et al.
Tropical Medicine & International Health : TM & IH|February 24, 2015
Adverse drug reaction reports for cardiometabolic drugs from sub-Saharan Africa: a study in VigiBaseDerbew Fikadu Berhe, Kristina Juhlin, Kristina Star, et al.
European Journal of Heart Failure|October 10, 2006
Prescription of beta-blockers in patients with advanced heart failure and preserved left ventricular ejection fraction. Clinical implications and survivalDaniela Dobre, Dirk J van Veldhuisen, Mike J L DeJongste, et al.
BMJ Quality & Safety|November 8, 2013
The effect of a clinical pharmacist-led training programme on intravenous medication errors: a controlled before and after studyHuong-Thao Nguyen, Hong-Tham Pham, Dang-Khoa Vo, et al.
Drug Safety|May 22, 2010
A decade of safety-related regulatory action in the Netherlands: a retrospective analysis of direct healthcare professional communications from 1999 to 2009Peter G M Mol, Sabine M J M Straus, Sigrid Piening, et al.
European Journal of Clinical Pharmacology|May 25, 2005
Uptake of angiotensin II receptor blockers in the treatment of hypertensionJacoba P Greving, Petra Denig, Willem Jan van der Veen, et al.
American Heart Journal|June 23, 2007
Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trialDaniela Dobre, Dirk J van Veldhuisen, Giacomo Mordenti, et al.
Journal of Hypertension|October 14, 2004
Does comorbidity explain trends in prescribing of newer antihypertensive agents?Jacoba P Greving, Petra Denig, Willem Jan van der Veen, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
British Journal of Clinical Pharmacology|April 22, 2017
Impact of adverse drug events and treatment satisfaction on patient adherence with antihypertensive medication - a study in ambulatory patientsDerbew Fikadu Berhe, Katja Taxis, Flora M Haaijer-Ruskamp, et al.
The Journal of Antimicrobial Chemotherapy|February 25, 2005
Improving compliance with hospital antibiotic guidelines: a time-series intervention analysisPeter G M Mol, Jaap E Wieringa, Prashant V Nannanpanday, et al.
Quality & Safety in Health Care|June 30, 2010
Comparison of methods for identifying patients at risk of medication-related harmJasperien E van Doormaal, Mirjam K Rommers, Jos G W Kosterink, et al.
Tropical Medicine & International Health : TM & IH|February 24, 2015
Adverse drug reaction reports for cardiometabolic drugs from sub-Saharan Africa: a study in VigiBaseDerbew Fikadu Berhe, Kristina Juhlin, Kristina Star, et al.
European Journal of Heart Failure|October 10, 2006
Prescription of beta-blockers in patients with advanced heart failure and preserved left ventricular ejection fraction. Clinical implications and survivalDaniela Dobre, Dirk J van Veldhuisen, Mike J L DeJongste, et al.
BMJ Quality & Safety|November 8, 2013
The effect of a clinical pharmacist-led training programme on intravenous medication errors: a controlled before and after studyHuong-Thao Nguyen, Hong-Tham Pham, Dang-Khoa Vo, et al.
Drug Safety|May 22, 2010
A decade of safety-related regulatory action in the Netherlands: a retrospective analysis of direct healthcare professional communications from 1999 to 2009Peter G M Mol, Sabine M J M Straus, Sigrid Piening, et al.
European Journal of Clinical Pharmacology|May 25, 2005
Uptake of angiotensin II receptor blockers in the treatment of hypertensionJacoba P Greving, Petra Denig, Willem Jan van der Veen, et al.
American Heart Journal|June 23, 2007
Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trialDaniela Dobre, Dirk J van Veldhuisen, Giacomo Mordenti, et al.
Journal of Hypertension|October 14, 2004
Does comorbidity explain trends in prescribing of newer antihypertensive agents?Jacoba P Greving, Petra Denig, Willem Jan van der Veen, et al.
Pageof 10